GlassScriptPhysician profile
Michelle Ferdinand Liu
NPI 1851371397
$5,463.51
in general payments reported to CMS, 2019-2025
16 companies · $2,374 in 2025
The $2,374 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.05 · 2022: $1,270 · 2023: $969 · 2024: $766 · 2025: $2,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,250 · Honoraria: $1,800 · Education: $58.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,250.38 |
| Honoraria | $1,800.00 |
| Education | $58.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $1,977.16 | 2022-2025 | Grastek, Ragwitek, Odactra |
| Medical Device Business Services, INC. | $877.62 | 2022 | |
| Glaxosmithkline, LLC. | $553.82 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $411.22 | 2022-2025 | Dupixent |
| Genzyme Corporation | $387.34 | 2023-2025 | |
| Acclarent, INC | $214.40 | 2022-2023 | Trudi Nav Cable |
| Integra Lifesciences Corporation | $207.59 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Medtronic, INC. | $200.99 | 2024 | Propel |
| Optinose US, INC. | $174.20 | 2022-2025 | |
| Aerin Medical INC. | $143.40 | 2024-2025 | |
| Kaleo, INC. | $84.93 | 2023-2024 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $84.05 | 2019 | |
| Stryker Corporation | $63.46 | 2025 | Audion Et Dilation System |
| Greer Laboratories, INC. | $37.46 | 2022-2025 | Oralair |
| Merck Sharp & Dohme LLC | $24.92 | 2025 | Keytruda |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $20.95 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.